IL10 and neoplasm: For instance, the systemic immune inflammation index, and the levels of tumor‐infiltrating immune cells, urinary IL‐10, serum cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4), and transcription factors can predict BCG response.41, 42